Mera Pharmaceuticals, Inc. (MRPI)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
Mera Pharmaceuticals Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2011 | 0.0452M |
| July 31, 2011 | 0.0406M |
| April 30, 2011 | 0.0494M |
| January 31, 2011 | 0.0379M |
| October 31, 2010 | 0.0616M |
| July 31, 2010 | 0.0703M |
| April 30, 2010 | 0.0705M |
| January 31, 2010 | 0.0629M |
| October 31, 2009 | 0.0723M |
| July 31, 2009 | 0.0827M |
| April 30, 2009 | 0.0728M |
| January 31, 2009 | 0.0967M |
| October 31, 2008 | 0.1175M |
| July 31, 2008 | 0.0647M |
| April 30, 2008 | 0.0682M |
| January 31, 2008 | 0.0511M |
| October 31, 2007 | 0.0554M |
| July 31, 2007 | 0.046M |
| April 30, 2007 | 0.0473M |
| January 31, 2007 | 0.0525M |
| October 31, 2006 | 0.035M |
| July 31, 2006 | 0.0265M |
| April 30, 2006 | 0.0368M |
| January 31, 2006 | 0.0607M |
| October 31, 2005 | 0.0481M |
| Date | Value |
|---|---|
| July 31, 2005 | 0.0762M |
| April 30, 2005 | 0.0232M |
| January 31, 2005 | 0.0216M |
| October 31, 2004 | 0.0303M |
| July 31, 2004 | 0.0448M |
| April 30, 2004 | 0.0289M |
| January 31, 2004 | 0.0073M |
| October 31, 2003 | 0.0154M |
| July 31, 2003 | 0.0318M |
| April 30, 2003 | 0.0556M |
| January 31, 2003 | 0.231M |
| October 31, 2002 | 0.4059M |
| July 31, 2002 | 0.1735M |
| April 30, 2002 | 0.0825M |
| January 31, 2002 | 0.2508M |
| October 31, 2001 | |
| July 31, 2001 | 0.2132M |
| April 30, 2001 | 0.2818M |
| January 31, 2001 | 0.4337M |
| October 31, 2000 | |
| July 31, 2000 | 0.7217M |
| April 30, 2000 | 0.553M |
| January 31, 2000 | 0.5578M |
| October 31, 1999 | |
| July 31, 1999 | 0.5153M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 192.06M |
| Oncolytics Biotech, Inc. | 4.262M |
| Sangamo Therapeutics, Inc. | 26.57M |
| Sarepta Therapeutics, Inc. | 91.26M |
| Anixa Biosciences, Inc. | 1.326M |